.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
UBS
Merck
Medtronic
McKesson
Baxter
Healthtrust
Fuji
Federal Trade Commission
Dow

Generated: December 15, 2017

DrugPatentWatch Database Preview

ERYTHROMYCIN ETHYLSUCCINATE Drug Profile

« Back to Dashboard

Which patents cover Erythromycin Ethylsuccinate, and what generic alternatives are available?

Erythromycin Ethylsuccinate is a drug marketed by Ani Pharms Inc, Alpharma Us Pharms, Dista, Naska, Parke Davis, Pharmafair, Arbor Pharms Llc, Barr, and Mylan. and is included in eleven NDAs.

The generic ingredient in ERYTHROMYCIN ETHYLSUCCINATE is erythromycin ethylsuccinate; sulfisoxazole acetyl. There are ninety-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate; sulfisoxazole acetyl profile page.
Drug patent expirations by year for ERYTHROMYCIN ETHYLSUCCINATE

Pharmacology for ERYTHROMYCIN ETHYLSUCCINATE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Ani Pharms IncERYTHROMYCIN ETHYLSUCCINATEerythromycin ethylsuccinateGRANULE;ORAL062055-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisERYTHROMYCIN ETHYLSUCCINATEerythromycin ethylsuccinateSUSPENSION;ORAL062231-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
DistaERYTHROMYCIN ETHYLSUCCINATEerythromycin ethylsuccinateSUSPENSION;ORAL062177-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrERYTHROMYCIN ETHYLSUCCINATEerythromycin ethylsuccinateTABLET;ORAL062256-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Parke DavisERYTHROMYCIN ETHYLSUCCINATEerythromycin ethylsuccinateSUSPENSION;ORAL062231-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYLerythromycin ethylsuccinate; sulfisoxazole acetylGRANULE;ORAL062759-001May 20, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Alpharma Us PharmsERYTHROMYCIN ETHYLSUCCINATEerythromycin ethylsuccinateSUSPENSION;ORAL062200-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Alpharma Us PharmsERYTHROMYCIN ETHYLSUCCINATEerythromycin ethylsuccinateSUSPENSION;ORAL062200-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
NaskaERYTHROMYCIN ETHYLSUCCINATEerythromycin ethylsuccinateSUSPENSION;ORAL062674-001Mar 10, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
DistaERYTHROMYCIN ETHYLSUCCINATEerythromycin ethylsuccinateSUSPENSION;ORAL062177-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Healthtrust
US Department of Justice
Dow
Cerilliant
Harvard Business School
Daiichi Sankyo
Boehringer Ingelheim
Federal Trade Commission
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot